Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec 1:14:17.
doi: 10.1186/s12948-016-0055-y. eCollection 2016.

Eosinophilic disorders of the gastro-intestinal tract: an update

Affiliations
Review

Eosinophilic disorders of the gastro-intestinal tract: an update

Erminia Ridolo et al. Clin Mol Allergy. .

Abstract

Eosinophilic diseases of the gastrointestinal tract, including eosinophilic esophagitis (EoE) and eosinophilic gastroenteritis (EGE), are rare chronic pathologies of the digestive system, with an immuno-mediated pathogenesis. Recent data suggest that, together with the "classic" IgE-response to allergens, also a delayed hypersensitivity mechanism could be involved in the development of eosinophilic disorders. EoE and EGE were studied only in the latest decades and as a consequence accurate data are not yet available, concerning not only pathogenesis, but also epidemiology, treatment and outcomes. The diagnosis of EoE is centered on endoscopic findings but the certainty is obtained by histological examination from biopsy samples, that has a sensitivity of 100% when based on five samples. The currently available treatments include topical corticosteroids, specific diets and endoscopic treatment. Concerning EGE, three subtypes (mucosal, muscular, and serosal) were identified. The diagnosis is based, as for EoE, on endoscopic and histological assessment, and the treatment includes pharmacological and dietetic approaches. Further studies are warranted in order to better define the etiology and pathogenesis of eosinophilic diseases of the gastrointestinal tract, and thus to develop more appropriate and specific therapies.

Keywords: Diagnosis; Eosinophilic esophagitis; Eosinophilic gastroenteritis; Pathogenesis; Therapy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
EoE
Fig. 2
Fig. 2
Hematoxylin-eosin, 20× magnification: Frustule of esophageal mucosa with diffuse infiltration of eosinophils (Eo > 20/HPF), microabscesses, disruption of the epithelial barrier
Fig. 3
Fig. 3
Same sample of Fig. 2 in Giemsa, 20× magnification: diffuse eosinophilic infiltration with microabscesses, it can be appreciate also the intercellular edema and the acantholysis resulting from the eosinophils’ degranulation
Fig. 4
Fig. 4
Eosinophilic gastroduodenitis, bulb mucosa
Fig. 5
Fig. 5
Eosinophilic colitis

References

    1. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20. doi: 10.1016/j.jaci.2011.02.040. - DOI - PubMed
    1. Hruz P. Epidemiology of eosinophilic esophagitis. Dig Dis. 2014;32:40–47. doi: 10.1159/000357008. - DOI - PubMed
    1. van Rhijn BD, Verheij J, et al. Rapidly increasing incidence of eosinophilic esophagitis in a large court. Neurogastroenterol Motil. 2013;25:47–52. doi: 10.1111/nmo.12009. - DOI - PubMed
    1. Spergel JM. New genetic links in eosinophilic esophagitis. Genome Med. 2010;2:60. doi: 10.1186/gm181. - DOI - PMC - PubMed
    1. Guarino MPL, Cicala M, Behar J. Eosinophilic esophagitis: new insight in pathogenesis and therapy. World J Gastroinest Pharmacol Ther. 2016;7(1):66–77. doi: 10.4292/wjgpt.v7.i1.66. - DOI - PMC - PubMed

LinkOut - more resources